Alpha Tau Medical Announces Completion Of Enrollment Of 48 Patients In Phase Pilot IMPACT Study Of Alpha DaRT With First-Line Chemotherapy In Unresectable Pancreatic Cancer; Targets Initial Data Early 2027

뉴스 본문을 불러오고 있어요.

Alpha Tau Medical Announces Completion Of Enrollment Of 48 Patients In Phase Pilot IMPACT Study Of Alpha DaRT With First-Line Chemotherapy In Unresectable Pancreatic Cancer; Targets Initial Data Early 2027 | 웨이프 WAPE

Alpha Tau Medical Announces Completion Of Enrollment Of 48 Patients In Phase Pilot IMPACT Study Of Alpha DaRT With First-Line Chemotherapy In Unresectable Pancreatic Cancer; Targets Initial Data Early 2027

기사 요약

관련 종목

댓글 —